Oleoylethanolamide (OEA): Key Applications in Pharmaceutical Research and Development
Oleoylethanolamide (OEA), a naturally occurring fatty acid ethanolamide with CAS number 111-58-0, is garnering significant attention in the pharmaceutical industry. Known for its potent activity as a PPAR-alpha agonist, OEA plays a vital role in regulating appetite, energy expenditure, and lipid metabolism. NINGBO INNO PHARMCHEM CO.,LTD., a reputable manufacturer and supplier from China, provides high-purity OEA to facilitate cutting-edge pharmaceutical research and development.
The core value of Oleoylethanolamide lies in its mechanism of action as a PPAR-alpha agonist. This receptor plays a critical role in regulating genes involved in fatty acid metabolism and energy homeostasis. Studies have consistently demonstrated that OEA administration can lead to a reduction in food intake and body weight gain, highlighting its potential in the treatment of obesity and related metabolic conditions such as arteriosclerosis. The phrase Oleoylethanolamide uses in pharmaceutical contexts often revolves around these metabolic benefits.
As a pharmaceutical intermediate, OEA offers a unique starting point for developing novel therapeutics. Its endogenous nature suggests a favorable safety profile, and ongoing research into its biosynthesis and biological functions continues to reveal new therapeutic possibilities. The investigation into OEA for weight loss is a prime example of its pharmaceutical relevance, as it provides a natural pathway to manage body weight.
NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting the pharmaceutical sector by supplying premium quality Oleoylethanolamide. Our product's high purity and consistent quality are essential for reproducible research and the development of effective drug candidates. Understanding the intricate Oleoylethanolamide properties is crucial for researchers aiming to harness its therapeutic potential. Whether it's exploring its effects on gut-brain signaling or its role in lipid metabolism, OEA stands out as a compound of significant interest.
Furthermore, the growing interest in endogenous lipid signaling pathways positions OEA as a valuable tool for understanding complex physiological processes. For companies involved in the synthesis of active pharmaceutical ingredients (APIs) or the formulation of metabolic health products, OEA represents a promising compound. Leverage the expertise of NINGBO INNO PHARMCHEM CO.,LTD. for your Oleoylethanolamide supply needs and advance your pharmaceutical innovations.
The core value of Oleoylethanolamide lies in its mechanism of action as a PPAR-alpha agonist. This receptor plays a critical role in regulating genes involved in fatty acid metabolism and energy homeostasis. Studies have consistently demonstrated that OEA administration can lead to a reduction in food intake and body weight gain, highlighting its potential in the treatment of obesity and related metabolic conditions such as arteriosclerosis. The phrase Oleoylethanolamide uses in pharmaceutical contexts often revolves around these metabolic benefits.
As a pharmaceutical intermediate, OEA offers a unique starting point for developing novel therapeutics. Its endogenous nature suggests a favorable safety profile, and ongoing research into its biosynthesis and biological functions continues to reveal new therapeutic possibilities. The investigation into OEA for weight loss is a prime example of its pharmaceutical relevance, as it provides a natural pathway to manage body weight.
NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting the pharmaceutical sector by supplying premium quality Oleoylethanolamide. Our product's high purity and consistent quality are essential for reproducible research and the development of effective drug candidates. Understanding the intricate Oleoylethanolamide properties is crucial for researchers aiming to harness its therapeutic potential. Whether it's exploring its effects on gut-brain signaling or its role in lipid metabolism, OEA stands out as a compound of significant interest.
Furthermore, the growing interest in endogenous lipid signaling pathways positions OEA as a valuable tool for understanding complex physiological processes. For companies involved in the synthesis of active pharmaceutical ingredients (APIs) or the formulation of metabolic health products, OEA represents a promising compound. Leverage the expertise of NINGBO INNO PHARMCHEM CO.,LTD. for your Oleoylethanolamide supply needs and advance your pharmaceutical innovations.
Perspectives & Insights
Data Seeker X
“for your Oleoylethanolamide supply needs and advance your pharmaceutical innovations.”
Chem Reader AI
“Oleoylethanolamide (OEA), a naturally occurring fatty acid ethanolamide with CAS number 111-58-0, is garnering significant attention in the pharmaceutical industry.”
Agile Vision 2025
“Known for its potent activity as a PPAR-alpha agonist, OEA plays a vital role in regulating appetite, energy expenditure, and lipid metabolism.”